Pharmacy College Collaborates With Educators From Japan

In the continued effort to extend their global reach, the administration and faculty at the James L. Winkle College of Pharmacy recently hosted health care professionals from the Health Professional Development Center at the Chiba University Hospital in Chiba, Japan.

The visitors, Daniel Salcedo, MD, and Tomoko Yamado-Inagawa, PhD, were at UC for four days to observe the Academic Health Center’s best practices for multi-cultural awareness.  Two representatives from Winkle College of Pharmacy acted as hosts: associate professor Alex Lin, PhD, and Pat Achoe, MBA, RPh, Director of Equity and Inclusion.

Lin and Achoe assisted the visitors with the development of a multicultural competency program.

"This visit, along with our other activities this year, align with our goal of expanding our global footprint as a college, " says Neil MacKinnon, PhD, Dean of the Winkle College of Pharmacy. "We are developing deep and ongoing partnerships with select universities and hospitals in select parts of the globe.”

In September, the college signed agreements with two universities in China for collaborative academic programs in cosmetic science and drug development and also sent the first cohort of PharmD students to Chile for a study abroad experience. New study abroad opportunities for PharmD students are being developed in 2018 in Scotland and Italy. 

Tags

Related Stories

1

Recent advances may speed time to endometriosis diagnosis

March 16, 2026

The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.

3

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.